Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 5 Colorectal Neoplasms 4 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Transitional Cell 3 Anus Neoplasms 3 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Virus Diseases 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Disease 1 Dermatitis 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1 Adenoviridae Infections 1

Interventions

ioflupane 1 daratumumab 1 alovudine 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03335059 2020-04-15

RITE-USA

Medical Enterprises Ltd.

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡